阿拉玛生物科学
ALMR
25.28
-2.14
-7.80%
阿拉玛生物科学
US · ALMR
#2657 按市值排名
上市于 2026
25.28
-2.14
-7.80%
实时 - 追踪5344个代码 - 心跳于9秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.1个百分点。
机构持股
- 机构持股比例
- 66.68% -0.15pp
- 机构数量
- 107 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
VC/PE Fund42.42%
Mutual Fund16.00%
Individual/Insider10.44%
Hedge Fund7.65%
Government Pension Fund0.30%
Public Company0.16%
Family Office/Trust0.11%
Other22.88%
主要股东 截至 2026-06-30
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
15.27% · 10.59M 股
IIF Management Company LLC
9.17% · 6.36M 股
Zhuhai Sherpa Equity Investment Management Company Limited
6.91% · 4.80M 股
Sands Capital Alternatives, LLC
6.10% · 4.23M 股
Yuling Luo
4.45% · 3.09M 股
Lian Luo
4.29% · 2.98M 股
Samsara BioCapital LLC
3.57% · 2.48M 股
T. Rowe Price Group, Inc.
3.19% · 2.21M 股
ARK Investment Management LLC
1.98% · 1.37M 股
Braidwell LP
1.56% · 1.08M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 23次买入 · 13次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | -- | 15.27% |
| Yuling Luo | Chairperson & CEO | 4.45% |
| Shiping Chen | Founder, COO & Director | 1.04% |
| Timothy White | President | 0.66% |
| Nicholas Naclerio | Independent Director | -- |
| Franklin Witney | Independent Director | -- |
| Robert Ragusa | Director | -- |
| IIF Management Company LLC | -- | -- |
| Justin McAnear | Chief Financial Officer | -- |
| Rebecca Chambers | Independent Director | -- |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-13 | John Brottem | General Counsel | Other Acquisition | +29,000 | -- |
| 2026-09-13 | John Brottem | General Counsel | Other Derivative Acquisition | +85,000 | $27.99 |
| 2026-08-31 | Robert Ragusa | Director | Other Acquisition | +5,686 | -- |
| 2026-08-31 | Robert Ragusa | Director | Other Derivative Acquisition | +25,599 | $29.36 |
| 2026-04-19 | Nicholas Naclerio | Independent Director | Other Acquisition | +5,686 | -- |
| 2026-04-19 | Franklin Witney | Independent Director | Other Derivative Acquisition | +206,781 | $0.59–7.60 |
| 2026-04-19 | Franklin Witney | Independent Director | Other Derivative Disposition | -206,781 | $0.59–7.60 |
| 2026-04-19 | Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | -- | Other Acquisition | +10,594,547 | -- |
| 2026-04-19 | Qiming Weichuang Venture Capital Management (Shanghai) Company Limited | -- | Derivative Exercise and Sale | -10,594,547 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Derivative Acquisition | +1,817,853 | $1.53–17.00 |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Acquisition | +76,509 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Acquisition | +3,088,217 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Disposition | -113,051 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Derivative Exercise and Sale | -2,975,166 | -- |
| 2026-04-19 | Yuling Luo | Chairperson & CEO | Other Derivative Disposition | -1,476,662 | $1.53–7.60 |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Derivative Acquisition | +464,241 | $3.34–17.00 |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Acquisition | +37,220 | -- |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Acquisition | +722,885 | -- |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Other Disposition | -329,521 | -- |
| 2026-04-19 | Shiping Chen | Founder, COO & Director | Derivative Exercise and Sale | -393,364 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
阿拉玛生物科学 讨论区 0 条评论